Introducing BioExecutive International -- A New Publication Dedicated to Building the New Biotech Leadership

Sep 22, 2004, 01:00 ET from T&F Informa

    WESTBOROUGH, Mass., Sept. 22 /PRNewswire/ -- T&F Informa today proudly
 announced the launch of BioExecutive International, its new business and
 marketing publication for the biotech industry.
     BioExecutive International (BEI) will be published 6 times annually,
 debuting with a Dec 04/Jan 05 issue as a sister publication to BioProcess
 International, the leading international publication devoted to development
 and manufacture of biotherapeutics and biodiagnostics.
     (Please click here http://www.bioprocessintl.com/pdf/BEI2005planner.pdf to
 view BEI's 2005 Media planner)
     "The biotechnology industry is ready and the timing is perfect for a
 publication dedicated specifically to today's bioexecutives," said Wayne
 Koberstein (wkoberstein@bioexecutiveintl.com), BEI's Editor in Chief, and 18-
 year veteran of B-to-B publishing for the pharmaceutical and biopharmaceutical
 industries.  "BioExecutive International will lead the biopharma management
 community in developing new business strategies and skills; help biotech
 companies become better business partners, product developers, and marketers;
 and protect and promote the unique entrepreneurial spirit and innovative force
 of the biopharma industry, as its companies and executives grow ever more
 sophisticated."
     "BioExecutive International's pre-qualified worldwide circulation will
 consist of 14,000 senior executives (defined as CEO, CFO, COO, CTO, EVP, VP,
 Managing Director, Project/Department Manager, Sales/Marketing Manager titles)
 working for companies and organizations whose primary business is the
 discovery, development, and marketing of biopharmaceutical products.
     Every issue of BioExecutive International will deliver information and
 insights focused on: strategic planning, executive education, HR management,
 finance, infrastructure, product development, investor and public relations,
 marketing, and many other critical areas of executive responsibility.  BEI
 will feature a balanced mix of executive interviews, benchmarking case
 studies, special reports, expert articles and columns, and a wealth of news,
 commentary, and assorted departments that will provide its executive audience
 with a host of needed tools for building the new biotech leadership.
     "In BioExecutive International, we have created a unique forum for vendors
 to effectively reach and introduce their company's expertise to a targeted,
 qualified group of executives working in the biotechnology industry," says
 Brian Caine, BEI's Publisher.  "BioExecutive International's comprehensive
 marketing programs, which include print and online advertising, electronic
 marketing, direct mail, and market research, offer vendors a generous return
 on their advertising investment.  We look forward to partnering with our
 advertisers to develop marketing plans that deliver results."
 
     BioExecutive International's Dec 04/Jan 05 editorial lineup includes:
     * An exclusive interview with Millennium's CEO Mark Levin
     * Two special reports:
       -- Biotech 2004 In Review, by Steve Burrill (Burrill & Company)
       -- Biotech 2005 In Preview, by Mark Dibner (BioAbility LLC)
     * Featured Articles:
       -- Business Cases:      "Does a Biogenerics Industry Really Exist?"
       -- Regulation:          "The Battle over Generic Biologics: How will
                          Healthcare Consumers Best Be Served."
       -- Executive Acumen:    "Business & Marketing Education for
                               BioExecutives."
       -- Strategic Supply
          Chains:              "Bio-Product Life-Cycle Management"
     * Profiled Columns:
       -- The Editor's Letter: "The Gene of Hope"
       -- Legal Labyrinth:     "TOPIC TBD"
       -- Investment
          Strategist:          "Earning Investors' Respect - First
                               Encounters Matter"
     * Regular Departments:
       -- News & Views
       -- Companies to Watch
       -- Discovery Zones
       -- Released News
       -- ExecUtips
 
     Please click here http://www.bioprocessintl.com/pdf/BEI2005planner.pdf to
 learn more about BioExecutive International, and please contact:
     Brian Caine, Publisher 508-614-1443, bcaine@bioexecutiveintl.com
     Jim Cheney, Sales Executive 212-262-8230, jcheney@bioexecutiveintl.com
 
     Please click here http://www.bioprocessintl.com/pdf/BEI2005authors.pdf for
 Article/Author guidelines, and contact:
 
      Wayne Koberstein, Editor in Chief
      541-345-9190, wkoberstein@bioexecutiveintl.com
      Christina Prier Steffy, Managing Editor
      541-345-5126 csteffy@bioexecutiveintl.com
 
     About T&F Informa
     BioExecutive International is part of the T&F Informa Life Sciences Group,
 the leading provider of scientific, technological and business information to
 the global life science community.  Other members of the T&F Informa Life
 Sciences Group include:  IBC Life Sciences, producer of industry leading
 biopharmaceutical conferences and courses, Drug & Market Development
 Publications - publishers of market analysis reports and hands-on How To
 Guides in the bioprocessing area, BioProcess International, BioTechniques, as
 well as PJB Publications which include: Scrip Word Pharmaceutical News, Scrip
 Magazine, Clinica, and Instrumenta.
 
 

SOURCE T&F Informa
    WESTBOROUGH, Mass., Sept. 22 /PRNewswire/ -- T&F Informa today proudly
 announced the launch of BioExecutive International, its new business and
 marketing publication for the biotech industry.
     BioExecutive International (BEI) will be published 6 times annually,
 debuting with a Dec 04/Jan 05 issue as a sister publication to BioProcess
 International, the leading international publication devoted to development
 and manufacture of biotherapeutics and biodiagnostics.
     (Please click here http://www.bioprocessintl.com/pdf/BEI2005planner.pdf to
 view BEI's 2005 Media planner)
     "The biotechnology industry is ready and the timing is perfect for a
 publication dedicated specifically to today's bioexecutives," said Wayne
 Koberstein (wkoberstein@bioexecutiveintl.com), BEI's Editor in Chief, and 18-
 year veteran of B-to-B publishing for the pharmaceutical and biopharmaceutical
 industries.  "BioExecutive International will lead the biopharma management
 community in developing new business strategies and skills; help biotech
 companies become better business partners, product developers, and marketers;
 and protect and promote the unique entrepreneurial spirit and innovative force
 of the biopharma industry, as its companies and executives grow ever more
 sophisticated."
     "BioExecutive International's pre-qualified worldwide circulation will
 consist of 14,000 senior executives (defined as CEO, CFO, COO, CTO, EVP, VP,
 Managing Director, Project/Department Manager, Sales/Marketing Manager titles)
 working for companies and organizations whose primary business is the
 discovery, development, and marketing of biopharmaceutical products.
     Every issue of BioExecutive International will deliver information and
 insights focused on: strategic planning, executive education, HR management,
 finance, infrastructure, product development, investor and public relations,
 marketing, and many other critical areas of executive responsibility.  BEI
 will feature a balanced mix of executive interviews, benchmarking case
 studies, special reports, expert articles and columns, and a wealth of news,
 commentary, and assorted departments that will provide its executive audience
 with a host of needed tools for building the new biotech leadership.
     "In BioExecutive International, we have created a unique forum for vendors
 to effectively reach and introduce their company's expertise to a targeted,
 qualified group of executives working in the biotechnology industry," says
 Brian Caine, BEI's Publisher.  "BioExecutive International's comprehensive
 marketing programs, which include print and online advertising, electronic
 marketing, direct mail, and market research, offer vendors a generous return
 on their advertising investment.  We look forward to partnering with our
 advertisers to develop marketing plans that deliver results."
 
     BioExecutive International's Dec 04/Jan 05 editorial lineup includes:
     * An exclusive interview with Millennium's CEO Mark Levin
     * Two special reports:
       -- Biotech 2004 In Review, by Steve Burrill (Burrill & Company)
       -- Biotech 2005 In Preview, by Mark Dibner (BioAbility LLC)
     * Featured Articles:
       -- Business Cases:      "Does a Biogenerics Industry Really Exist?"
       -- Regulation:          "The Battle over Generic Biologics: How will
                          Healthcare Consumers Best Be Served."
       -- Executive Acumen:    "Business & Marketing Education for
                               BioExecutives."
       -- Strategic Supply
          Chains:              "Bio-Product Life-Cycle Management"
     * Profiled Columns:
       -- The Editor's Letter: "The Gene of Hope"
       -- Legal Labyrinth:     "TOPIC TBD"
       -- Investment
          Strategist:          "Earning Investors' Respect - First
                               Encounters Matter"
     * Regular Departments:
       -- News & Views
       -- Companies to Watch
       -- Discovery Zones
       -- Released News
       -- ExecUtips
 
     Please click here http://www.bioprocessintl.com/pdf/BEI2005planner.pdf to
 learn more about BioExecutive International, and please contact:
     Brian Caine, Publisher 508-614-1443, bcaine@bioexecutiveintl.com
     Jim Cheney, Sales Executive 212-262-8230, jcheney@bioexecutiveintl.com
 
     Please click here http://www.bioprocessintl.com/pdf/BEI2005authors.pdf for
 Article/Author guidelines, and contact:
 
      Wayne Koberstein, Editor in Chief
      541-345-9190, wkoberstein@bioexecutiveintl.com
      Christina Prier Steffy, Managing Editor
      541-345-5126 csteffy@bioexecutiveintl.com
 
     About T&F Informa
     BioExecutive International is part of the T&F Informa Life Sciences Group,
 the leading provider of scientific, technological and business information to
 the global life science community.  Other members of the T&F Informa Life
 Sciences Group include:  IBC Life Sciences, producer of industry leading
 biopharmaceutical conferences and courses, Drug & Market Development
 Publications - publishers of market analysis reports and hands-on How To
 Guides in the bioprocessing area, BioProcess International, BioTechniques, as
 well as PJB Publications which include: Scrip Word Pharmaceutical News, Scrip
 Magazine, Clinica, and Instrumenta.
 
 SOURCE  T&F Informa